Trial intelligence / Profile preview

Penthrox for Pain Control in Aesthetic Procedures

NCT04292808Withdrawn

Sponsor
Verso Surgery Centre
Start
Jul 2020
Primary completion
Jul 2021
Modality
Allosteric Modulators
Countries
1
01

Overview

Open-label, single-arm trial of methoxyflurane in pain, sponsored by Verso Surgery Centre. Primary endpoint: Assessing patient satisfaction at 1 year. Planned start Jul 2020; status: withdrawn.

02

Drugs

methoxyflurane
03

Conditions

pain

Beyond the preview

Go deeper on NCT04292808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04292808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call